BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15547048)

  • 1. Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study.
    Obach RS; Cox LM; Tremaine LM
    Drug Metab Dispos; 2005 Feb; 33(2):262-70. PubMed ID: 15547048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar.
    Zhang D; Wang L; Chandrasena G; Ma L; Zhu M; Zhang H; Davis CD; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):139-49. PubMed ID: 17062778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
    Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H
    Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of human cytochrome P450 and flavin-containing monooxygenase enzymes involved in the metabolism of lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist.
    Usmani KA; Chen WG; Sadeque AJ
    Drug Metab Dispos; 2012 Apr; 40(4):761-71. PubMed ID: 22266842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes.
    Kim KA; Kim MJ; Park JY; Shon JH; Yoon YR; Lee SS; Liu KH; Chun JH; Hyun MH; Shin JG
    Drug Metab Dispos; 2003 Oct; 31(10):1227-34. PubMed ID: 12975331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.
    Akutsu T; Kobayashi K; Sakurada K; Ikegaya H; Furihata T; Chiba K
    Drug Metab Dispos; 2007 Jan; 35(1):72-8. PubMed ID: 17020955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of diuron N-demethylation by mammalian hepatic microsomes and cDNA-expressed human cytochrome P450 enzymes.
    Abass K; Reponen P; Turpeinen M; Jalonen J; Pelkonen O
    Drug Metab Dispos; 2007 Sep; 35(9):1634-41. PubMed ID: 17576805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterization of the metabolic pathways and cytochrome P450 inhibition and induction potential of BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor.
    Hong H; Su H; Ma L; Yao M; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2011 Sep; 39(9):1658-67. PubMed ID: 21673131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2B6, CYP2D6, and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomes.
    Davies BJ; Coller JK; Somogyi AA; Milne RW; Sallustio BC
    Drug Metab Dispos; 2007 Jan; 35(1):128-38. PubMed ID: 17050648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
    Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
    Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
    Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.
    Kilford PJ; Stringer R; Sohal B; Houston JB; Galetin A
    Drug Metab Dispos; 2009 Jan; 37(1):82-9. PubMed ID: 18832476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems.
    Salonen JS; Nyman L; Boobis AR; Edwards RJ; Watts P; Lake BG; Price RJ; Renwick AB; Gómez-Lechón MJ; Castell JV; Ingelman-Sundberg M; Hidestrand M; Guillouzo A; Corcos L; Goldfarb PS; Lewis DF; Taavitsainen P; Pelkonen O
    Drug Metab Dispos; 2003 Sep; 31(9):1093-102. PubMed ID: 12920164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro.
    Kobayashi K; Ishizuka T; Shimada N; Yoshimura Y; Kamijima K; Chiba K
    Drug Metab Dispos; 1999 Jul; 27(7):763-6. PubMed ID: 10383917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKF525A, its metabolites, and SKF-acid and SKF-alcohol.
    Franklin MR; Hathaway LB
    Drug Metab Dispos; 2008 Dec; 36(12):2539-46. PubMed ID: 18799803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the main human cytochrome P450 enzymes involved in safrole 1'-hydroxylation.
    Ueng YF; Hsieh CH; Don MJ; Chi CW; Ho LK
    Chem Res Toxicol; 2004 Aug; 17(8):1151-6. PubMed ID: 15310247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolism of jaceosidin and characterization of cytochrome P450 and UDP-glucuronosyltransferase enzymes in human liver microsomes.
    Song WY; Ji HY; Baek NI; Jeong TS; Lee HS
    Arch Pharm Res; 2010 Dec; 33(12):1985-96. PubMed ID: 21191764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
    Nassar AE; King I; Paris BL; Haupt L; Ndikum-Moffor F; Campbell R; Usuki E; Skibbe J; Brobst D; Ogilvie BW; Parkinson A
    Drug Metab Dispos; 2009 Sep; 37(9):1922-30. PubMed ID: 19520774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series).
    Theobald DS; Maurer HH
    Biochem Pharmacol; 2007 Jan; 73(2):287-97. PubMed ID: 17067556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative contribution of monoamine oxidase and cytochrome p450 isozymes to the metabolic deamination of the trace amine tryptamine.
    Yu AM; Granvil CP; Haining RL; Krausz KW; Corchero J; Küpfer A; Idle JR; Gonzalez FJ
    J Pharmacol Exp Ther; 2003 Feb; 304(2):539-46. PubMed ID: 12538805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.